All Stories

  1. Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma

    Article • OncoTargets and Therapy, October 2018, Dove Medical Press

    Dr MADAPPA N KUNDRANDA, Sunilkumar Kakadia

  2. Nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreatic cancer: utility and experience from the clinic

    Article • Gastrointestinal Cancer Targets and Therapy, January 2016, Dove Medical Press

    Dr MADAPPA N KUNDRANDA

  3. Albumin-bound paclitaxel in solid tumors: clinical development and future directions

    Article • Drug Design Development and Therapy, July 2015, Dove Medical Press

    Dr MADAPPA N KUNDRANDA